Evidence map›Paper›PMID 28449602›Full record

ArticleInternational journal of immunopathology and pharmacology2017

Reference values for B-cell surface markers and co-receptors associated with primary immune deficiencies in healthy Turkish children.

Elif Azarsiz, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer

Open access · goldAbstract read
In one paragraph

Article in International journal of immunopathology and pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Two male siblings with a novelJMM case reports · 2018
    Article
  4. Gain-of-Function Mutations inCase reports in immunology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elif AzarsizDepartment of Pediatric Immunology, Faculty of Medicine, Ege University, Izmir, Turkey.
Neslihan Edeer KaracaDepartment of Pediatric Immunology, Faculty of Medicine, Ege University, Izmir, Turkey.
Guzide AksuDepartment of Pediatric Immunology, Faculty of Medicine, Ege University, Izmir, Turkey.
Necil KutukculerDepartment of Pediatric Immunology, Faculty of Medicine, Ege University, Izmir, Turkey.
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to evaluate B-lymphocyte subsets of patients with primary immunodeficiencies, the normal values for national healthy children have to be used as a reference. Recently, B-cell co-receptor markers (CD19, CD21, and CD81) and CD20, CD22, and CD27 deficiencies have been reported in relation with different primary immunodeficiency diseases. The objective of this study was to establish national reference values for B-lymphocyte co-receptors and some surface markers, CD20, CD22, CD27, as well as classic lymphocyte subsets in the peripheral blood of healthy children. A total of 90 healthy children were included in this study. Complete blood counts were performed and cells with CD3, CD4, CD8, CD19, CD16/56, CD20, CD21, CD22, CD27, and CD81 surface markers were simultaneously detected by flow cytometry. The children were evaluated in three age subgroups, 0-1, 1-6, and >6 years, and minimum, maximum, mean, mean minus standard deviation, and 2.5-97.5 percentile values were all determined. By establishing reliable reference ranges for these surface markers, we hoped to help identifying and classifying some primary immunodeficiency patients, especially those defined as unclassified hypogammaglobulinemia and those without definite diagnosis.

Indexed as

AdolescentAntigens, SurfaceB-LymphocytesChildChild, PreschoolFemaleHealthy VolunteersHumansImmunologic Deficiency SyndromesInfantInfant, NewbornMaleMembrane ProteinsReference ValuesTurkeyAntigens, SurfaceMembrane ProteinsB cellco-receptorlymphocyte surface markers

Identifiers

PMID28449602
PMCPMC5806800
OpenAlexW2608645713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.